Both in Pharmaceuticals
Atea Pharmaceuticals vs Enanta Pharmaceuticals
Over the past year AVIR returned +26.5% and ENTA returned −1.0%; their daily moves had a correlation of 0.33.
AVIR +26.5% ENTA −1.0%Growth of $1, one year, split-adjusted
| Metric | AVIR | ENTA |
|---|---|---|
| Price | $4.11 | $10.71 |
| Market cap | $329.6M | $311.9M |
| Today | −4.64% | −3.95% |
| 1 month | −19.4% | −16.6% |
| 6 months | −26.3% | −25.4% |
| Year to date | +15.1% | −32.1% |
| 1 year | +24.9% | +0.8% |
| Revenue growth (YoY) | — | −21.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −135.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.8× |
| Net cash | $219.5M | $189.5M |
| Dividend yield | — | — |
| Volatility (60d) | 46.4% | 45.8% |
| Short % of float | 5.0% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).